FIELD: medicine.
SUBSTANCE: invention refers to a method for patient-specific selection of antiplatelet drugs for the patients in need thereof involving patient's blood sampling, preparing platelet rich plasma by blood centrifugation, separating specimens and adding antiplatelet drugs thereto with the above preparations having the different mechanisms of antiplatelet action, incubating the plasma specimens with the preparations at temperature 36.5-37.5°C and an platelet aggregation inducer.
EFFECT: more accurate selection of the antiplatelet preparations for the patients in need thereof.
1 cl, 2 ex, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF REDUCING AGGREGATION ACTIVITY OF PLATELETS in vitro | 2009 |
|
RU2410104C1 |
| METHOD FOR STUDYING ANTI-AGGREGATION ACTION OF PREPARATIONS BY DETERMINING BLOOD PLATELET AGGREGATION IN VITRO | 2000 |
|
RU2188419C2 |
| METHOD FOR DETECTING ANTIPLATELET DRUG RESISTANCE IN PATIENTS WITH PROGRESSING CEREBRAL ATHEROSCLEROSIS | 2012 |
|
RU2478965C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2709017C1 |
| PHARMACEUTICAL COMBINATION POSSESSING ANTIAGGREGANT AND LIPID-REGULATING ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2461379C2 |
| ANTIPLATELET | 2023 |
|
RU2808529C1 |
| RGD-LIKE PEPTIDES | 2009 |
|
RU2396271C1 |
| METHOD FOR DETERMINING THROMBOCYTE RESISTANCE TO ANTIAGGREGANT PREPARATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2018 |
|
RU2686700C1 |
| COMBINATION POSSESSING ANTIAGGREGANT, LIPID-REGULATING AND GASTROPROTECTIVE ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2453314C1 |
| 2-CYCLOALKYLAMINO-5-THIENYL-1,3,4-THIADIAZINES, HYDROBROMIDES, WITH ANTIAGGREGANT ACTIVITY | 2008 |
|
RU2379306C1 |
